Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPT | ANIP | VCEL | ||
| Company | Rapt Therapeutics Inc | ANI Pharma Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 57.98 | 73.53 | 31.04 | ||
| High | 58.02 | 74.97 | 31.81 | ||
| Low | 57.98 | 73.53 | 30.51 | ||
| Latest | 58.02 | 74.14 | 30.82 | ||
| Change | +0.04 | +0.07 | -0.62 | ||
| % Change | +0.07% | +0.09% | -1.97% | ||
| Volume | 11,125,200 | 196,100 | 747,200 | ||
| 20-Day Average Volume | 4,642,485 | 406,020 | 702,855 | ||
| Previous Close | 57.98 | 74.07 | 31.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.82 | 74.35 | 33.11 | ||
| 20-Day Raw Stochastic | 100.00% | 50.83% | 4.97% | ||
| 20-Day Relative Strength | 76.09 | 44.99 | 37.42 | ||
| Weighted Alpha | +230.04 | -2.46 | -31.72 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/23/26 | -0.91% since 03/19/26 | -5.86% since 03/19/26 | ||
| Low | 57.91 on 02/24/26 | 72.82 on 03/24/26 | 30.51 on 03/26/26 | ||
| High | 58.02 on 03/02/26 | 75.95 on 03/23/26 | 34.34 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | +0.59% since 02/02/26 | -3.90% since 02/26/26 | -18.21% since 02/26/26 | ||
| Low | 57.61 on 02/04/26 | 70.15 on 03/13/26 | 30.51 on 03/26/26 | ||
| High | 58.02 on 03/02/26 | 78.00 on 02/27/26 | 36.75 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +79.46% since 12/02/25 | -10.04% since 12/26/25 | -18.16% since 12/26/25 | ||
| Low | 29.77 on 01/06/26 | 70.15 on 03/13/26 | 30.51 on 03/26/26 | ||
| High | 58.02 on 03/02/26 | 87.07 on 01/16/26 | 41.65 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +388.80% since 09/02/25 | -20.32% since 09/26/25 | +1.95% since 09/26/25 | ||
| Low | 11.19 on 09/04/25 | 70.15 on 03/13/26 | 29.88 on 09/29/25 | ||
| High | 58.02 on 03/02/26 | 97.00 on 10/24/25 | 43.00 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,607,792 | 1,660,204 | 1,601,302 | ||
| Shares Outstanding, K | 27,711 | 22,414 | 50,932 | ||
| Annual Sales | 0 | 883,370,000 | 276,260,000 | ||
| Annual Net Income | -129,870,000 | 78,340,000 | 16,520,000 | ||
| Last Quarter Sales | 0 | 247,060,000 | 92,920,000 | ||
| Last Quarter Net Income | -17,580,000 | 27,490,000 | 23,240,000 | ||
| 60-Month Beta | 0.49 | 0.52 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/06/25 | 2.33 on 02/27/26 | 0.45 on 02/26/26 | ||
| Latest Earnings Date | 03/05/26 | 05/08/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.51 | 106.71 | ||